Document is current
Any future updates will be listed below
-
Authors
Ewings, Sean
Saunders, Geoff
Jaki, Thomas
Mozgunov, Pavel
- License Information
-
More Information
Article History
Received: 3 September 2021
Accepted: 6 January 2022
First Online: 20 January 2022
Declarations
:
: The AGILE study was approved by the UK Medicines and Healthcare product Regulatory Agency (MHRA) (EudraCT 2020–001860-27) and West Midlands Edgbaston Research Ethics Committee (20/WM/0136). The research was carried out in accordance with the Declaration of Helsinki. All participants provided written informed consent before enrolment.
: Not applicable.
: All authors declare no competing interests.
